Jiazhen Jiang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Safety concerns associated with various types of statins: a disproportionality analysis of the FAERS database.
Journal: Expert opinion on drug safety
Published: April 03, 2026
Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance.
Journal: Expert opinion on drug safety
Published: June 30, 2025
Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system.
Journal: Frontiers in cardiovascular medicine
Published: May 27, 2025
The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer.
Journal: Expert opinion on drug safety
Published: April 08, 2025
Safety issues of Donepezil combined with Memantine in Alzheimer's disease population: real-world pharmacovigilance.
Journal: Expert opinion on drug safety
Published: February 14, 2025
Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System.
Journal: Expert opinion on drug safety
Published: October 25, 2024
Adverse reaction of specific acute kidney injury caused by atorvastatin: an actual study based on the database of the US FDA adverse event reporting system.
Journal: Expert opinion on drug safety
Published: October 16, 2024
Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system.
Journal: Frontiers in cardiovascular medicine
Published: October 01, 2024
Mulberry twig alkaloids for type 2 diabetes mellitus: a systematic review and meta-analysis.
Journal: Frontiers in pharmacology
Published: August 23, 2024
Adverse tumor events induced by ranitidine: an analysis based on the FAERS database.
Journal: Expert opinion on drug safety
Published: May 16, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026